CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Echothiophate Iodide Ophthalmic Solution
FDA source answer
FDA currently lists this ingredient in shortage.
FDA source statuses: Current. First FDA posting: 2019-09-24. Latest FDA row update: 2026-09-01.
FDA lists 1 package records, with companies: Fera Pharmaceuticals, Fera Pharmaceuticals, LLC. Package NDCs: 48102-053-05.
FDA shortage reason: Other
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| Fera Pharmaceuticals | 48102-053-05 | Phospholine Iodide, Ophthalmic Solution, 0.125% (NDC 48102-053-05) | Available | 2026-09-01 |
Source facts
Grouped generic ingredient: Echothiophate Iodide Ophthalmic Solution · 1 package records
Therapeutic categories: Ophthalmology
Dosage forms: Ophthalmic Solution
Routes: OPHTHALMIC
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.